BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33579498)

  • 1. Design strategies and evolving role of biomaterial assisted treatment of osteosarcoma.
    Quadros M; Momin M; Verma G
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111875. PubMed ID: 33579498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair.
    Zeng Y; Hoque J; Varghese S
    Acta Biomater; 2019 Jul; 93():152-168. PubMed ID: 30711659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery.
    Salve R; Kumar P; Ngamcherdtrakul W; Gajbhiye V; Yantasee W
    Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112084. PubMed ID: 33947574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silica nanoparticles: A promising platform for enhanced oral delivery of macromolecules.
    Abeer MM; Rewatkar P; Qu Z; Talekar M; Kleitz F; Schmid R; Lindén M; Kumeria T; Popat A
    J Control Release; 2020 Oct; 326():544-555. PubMed ID: 32687941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy.
    Küçüktürkmen B; Rosenholm JM
    Adv Exp Med Biol; 2021; 1295():99-120. PubMed ID: 33543457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering 2D Mesoporous Silica@MXene-Integrated 3D-Printing Scaffolds for Combinatory Osteosarcoma Therapy and NO-Augmented Bone Regeneration.
    Yang Q; Yin H; Xu T; Zhu D; Yin J; Chen Y; Yu X; Gao J; Zhang C; Chen Y; Gao Y
    Small; 2020 Apr; 16(14):e1906814. PubMed ID: 32108432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomaterials in treatment of Alzheimer's disease.
    Agrawal M; Prathyusha E; Ahmed H; Dubey SK; Kesharwani P; Singhvi G; Naidu VGM; Alexander A
    Neurochem Int; 2021 May; 145():105008. PubMed ID: 33684545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of mesoporous materials as excipients for innovative drug delivery and formulation.
    Shen SC; Ng WK; Chia LS; Dong YC; Tan RB
    Curr Pharm Des; 2013; 19(35):6270-89. PubMed ID: 23470004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silicon-polymer hybrid materials for drug delivery.
    McInnes SJ; Voelcker NH
    Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
    Dilnawaz F
    Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailored Mesoporous Inorganic Biomaterials: Assembly, Functionalization, and Drug Delivery Engineering.
    Zou Y; Huang B; Cao L; Deng Y; Su J
    Adv Mater; 2021 Jan; 33(2):e2005215. PubMed ID: 33251635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z; Zhang Y; Feng N
    Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional hybrid aerogels: hyperbranched polymer-trapped mesoporous silica nanoparticles for sustained and prolonged drug release.
    Follmann HDM; Oliveira ON; Lazarin-Bidóia D; Nakamura CV; Huang X; Asefa T; Silva R
    Nanoscale; 2018 Jan; 10(4):1704-1715. PubMed ID: 29308497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
    Chen Y; Chen H; Shi J
    Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic bioactive glass nano-heterostructures: a deeper insight into magnetic hyperthermia properties in the scope of bone cancer treatment.
    Vergnaud F; Kesse X; Jacobs A; Perton F; Begin-Colin S; Mertz D; Descamps S; Vichery C; Nedelec JM
    Biomater Sci; 2022 Jul; 10(14):3993-4007. PubMed ID: 35723414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.